Enochian Biosciences Inc. (ENOB) Fundamentals

Enochian BioSciences Inc is a biopharmaceutical company. It is engaged in identifying, developing, manufacturing, and commercializing gene therapies. The company develops cures and providing prevention for infectious diseases and cancer. It is also engaged in developing HIV preventative vaccines and cures and Cellular immune-oncology products.
SHARE INFORMATION
Market Cap$ 151,436,906
Shares Outstanding52,949,967
Float2,425,497
Percent Float4.58%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -0.57
Latest Fiscal Date2021-06-30
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions121
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months908,581
Institutional Holdings Percent10.7%
Institutional Sold Previous 3 Months655,045
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months91,892
Insider Holdings Percent6.4
Insider Sold Previous 3 Months253,493
Insider Shares Owned3,374,671
TRADING INFO
52 Week High$ 13.78
52 Week Low$ 1.42
52 Week High Change$ -48.28
21 Day Moving Average$ 2.2862
21 Day Extended Moving Average$ 2.482
50 Day Moving Average$ 2.8507
50 Day Extended Moving Average$ 3.1705
200 Day Moving Average$ 6.5267
200 Day Extended Moving Average$ 5.3073
10 Day Average Volume74,446
20 Day Average Volume128,994
30 Day Average Volume416,057
50 Day Average Volume557,346
Alpha0.026163
Beta0.9245
Standard Deviation0.241661
R20.036610
7 Day Price Change$ 0.56
7 Day Percent Change24.35%
21 Day Price Change$ 0.68
21 Day Percent Change31.19%
30 Day Price Change$ 0.59
30 Day Percent Change25.99%
Month to Date Price Change$ 0.56
Month to Date Percent Change24.35%
Quarter to Date Price Change$ 0.93
Quarter to Date Percent Change48.19%
180 Day Price Change$ -2.59
180 Day Percent Change-47.52%
200 Day Price Change$ -2.86
200 Day Percent Change-50.0%
Year to Date Price Change$ -4.43
Year to Date Percent Change-60.77%

Enochian Biosciences Inc. (ENOB) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book-28.70
Total Debt To Equity0.10
Int Coverage-106.90
Current Ratio1.60
Leverage Ratio1.10
Quick Ratio1.50
Long Term Debt To Capital0.01
VALUATION MEASURES
PE Ratio-3.50
Enterprise Value$ 147,602,020
Price to Sales0.00
Price to Free Cash-11.90
PE High Last 5 Years-16.70
Price To Book0.90
Price To Cash Flow0.00
PE Low Last 5 Years-13.50
Price to Tangible Book-28.70
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-23.57
Return on Equity-25.79
Return on Capital-23.78

Enochian Biosciences Inc. (ENOB) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorSadler, Gibb & Associates, LLC
CEOMark R. Dybul
Emplyoees11
Last AuditUQ
CIK0001527728
IndustryBiotechnology
SectorHealthcare
NAICSBiological Product (except Diagnostic) Manufacturing(325414)
CONTACT INFO
Address2080 Century Park East
Suite 906
Los Angeles, CA 90067-2012
Websitehttps://www.enochianbio.com
Facsimile-
Telephone+1 305 918-1980
Emaillpuche@enochianbio.com


Your Recent History
NASDAQ
ENOB
Enochian B..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.